Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe

NCT: NCT04565821 · ACTIVE_NOT_RECRUITING

NCT IDNCT04565821
StatusACTIVE_NOT_RECRUITING
Start Date2020-11-12
Completion2028-04-30
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to examine the feasibility of using a trans-nasal IPD probe as a measurement tool for gut permeability

Frequently Asked Questions

What is Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe?

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe is a clinical trial registered under NCT04565821. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04565821?

The current status of NCT04565821 (Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe) is: ACTIVE_NOT_RECRUITING.

When did Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe start?

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe started on 2020-11-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑